1. Home
  2. CDNA vs BKV Comparison

CDNA vs BKV Comparison

Compare CDNA & BKV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CareDx Inc.

CDNA

CareDx Inc.

N/A

Current Price

$66.83

Market Cap

2.6B

Sector

Health Care

ML Signal

N/A

Logo BKV Corporation

BKV

BKV Corporation

N/A

Current Price

$21.53

Market Cap

2.9B

Sector

Energy

ML Signal

N/A

Company Overview

Basic Information
Metric
CDNA
BKV
Founded
1998
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Oil & Gas Production
Sector
Health Care
Energy
Exchange
Nasdaq
Nasdaq
Market Cap
2.6B
2.9B
IPO Year
2007
2022

Fundamental Metrics

Financial Performance
Metric
CDNA
BKV
Price
$66.83
$21.53
Analyst Decision
Buy
Strong Buy
Analyst Count
7
11
Target Price
★ $58.83
$34.00
AVG Volume (30 Days)
1.0M
★ 2.1M
Earning Date
11-03-2026
11-09-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 199.00
EPS
★ 2.13
1.11
Revenue
$48,324,000.00
★ $893,781,000.00
Revenue This Year
$30.36
$46.52
Revenue Next Year
$6.23
N/A
P/E Ratio
$30.04
★ $19.63
Revenue Growth
18.93
★ 47.85
52 Week Low
$13.95
$20.08
52 Week High
$65.50
$32.81

Technical Indicators

Market Signals
Indicator
CDNA
BKV
Relative Strength Index (RSI) 78.88 32.89
Support Level $17.26 N/A
Resistance Level N/A $27.40
Average True Range (ATR) 2.87 0.82
MACD 0.90 -0.20
Stochastic Oscillator 99.39 9.49

Price Performance

Historical Comparison
CDNA
BKV

About CDNA CareDx Inc.

CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically it generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.

About BKV BKV Corporation

BKV Corp is a growth-driven energy company focused on the development of natural gas-producing assets, the ownership and operation of natural gas-fired power generation assets, and selective accretive acquisitions. The company's core businesses are the production of natural gas and the generation of natural gas-fired power from its owned and operated assets, supported by a closed-loop plan, enabled by its upstream, midstream, power, and CCUS businesses.

Share on Social Networks: